TCMBANKIN001459 |
pfaffic acid |
CHEBI:8036; C08965; AC1L9BYQ; DTXSID90331678; Pfaffic acid; 86432-14-6; LMPR0106250001 |
C29H44O3 |
440.7 g/mol |
CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CC5C6(CCC5(C4C6)C(=O)O)C)C)C)C |
TCMBANKIN033849 |
peucedanin |
HMS2675C08; Oprea1_837278; SMR000102964; AB00053108-02; NCGC00095695-02; BRD-K72034655-001-02-1; MLS001049116; 2-isopropyl-3-methoxy-7H-furo[3,2-g]chromen-7-one; 5-Benzofuranacrylic acid, 6-hydroxy-2-isopropyl-3-methoxy-, delta-lactone; BSPBio_003373; KBio2_007162; 5-19-06-00042 (Beilstein Handbook Reference); SCHEMBL2249089; CHEBI:8034; Spectrum4_001666; Spectrum5_000571; KBio2_004594; MolPort-000-882-022; 6-Hydroxy-2-isopropyl-3-methoxy-5-benzofuranacrylic acid delta-lactone; MCULE-2664497001; 3-methoxy-2-(propan-2-yl)-7H-furo[3,2-g]chromen-7-one; SPBio_000658; AC1L1RCV; 3-methoxy-2-propan-2-ylfuro[3,2-g]chromen-7-one; CHEMBL1410943; AKOS000278122; 4-Methoxy-5-isopropylfuro(2,3:6,7)coumarin; CCG-40070; KBioGR_002191; Oreoselone methyl ether; 2-isopropyl-3-methoxy-furo[3,2-g]chromen-7-one; KBioSS_002026; SPECTRUM1504168; KBio1_001992; NCGC00095695-01; ST50909203; 3-Methoxy-2-(1-methylethyl)-7H-furo(3,2-g)(1)benzopyran-7-one; STK396320; C09283; MEGxp0_001552; 7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 2-ISOPROPYL-3-METHOXY-; Spectrum3_001647; 7H-Furo[3,2-g][1]benzopyran-7-one,3-methoxy-2-(1-methylethyl)-; Spectrum_001546; LS-70731; Peutsedin; SpecPlus_000952; Bio-0240; YQBNJPACAUPNLV-UHFFFAOYSA-; CTK4B8448; N021633LOB; UNII-N021633LOB; 133-26-6; Peucedanin; Spectrum2_000729; 3-Methoxy-2-(1-methylethyl)-7 H -furo[3,2- g ][1]benzopyran-7-one; 2-Isopropyl-3-methoxy-7 H -furo[3,2- g ][1]benzopyran-7-one; SDCCGMLS-0066802.P001; KBio3_002593; DTXSID10157897; DivK1c_007048; InChI=1/C15H14O4/c1-8(2)14-15(17-3)10-6-9-4-5-13(16)18-11(9)7-12(10)19-14/h4-8H,1-3H3; NCGC00095695-03!3-methoxy-2-propan-2-ylfuro[3,2-g]chromen-7-one; KBio2_002026; ZINC1912; 6-methoxy-7-(methylethyl)furano[3,2-g]chromen-2-one; Oprea1_190644; BRN 0234473 |
C15H14O4 |
258.27 g/mol |
CC(C)C1=C(C2=C(O1)C=C3C(=C2)C=CC(=O)O3)OC |
TCMBANKIN059084 |
Byakangelicin |
(R)-9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; 9-[(2S)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one; 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxy-7-furo[3,2-g]chromenone; 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one; C09141; 7H-Furo(3,2-g)(1)benzopyran-7-one, 9-(2,3-dihydroxy-3-methylbutoxy)-4-methoxy-, (R)-; 9-(2,3-Dihydroxy-3-methylbutoxy)-4-methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; Byak-angelicin; Bjacangelicin; MLS000574875; Bjakangelicin; PKRPFNXROFUNDE-NSHDSACASA-N; SMR000156212; Biacangelicin; 7H-FURO(3,2-g)(1)BENZOPYRAN-7-ONE, 9-(2,3-DIHYDROXY-3-METHYLBUTOXY)-4-METHOXY-,; 9-[(2R)-2,3-dihydroxy-3-methyl-butoxy]-4-methoxy-furo[3,2-g]chromen-7-one; ZINC13380829; 482-25-7; AC1NST7W; Byankagelicine; (+)-Byakangelicin; byakangelicin; 9-(2,3-dihydroxy-2-methylbutoxy)-4-methoxy-7H-furo[3,2-g][l]benzopyran-7-one; byak-angelicin |
C17H18O7 |
334.3 g/mol |
CC(C)(C(COC1=C2C(=C(C3=C1OC(=O)C=C3)OC)C=CO2)O)O |
TCMBANKIN059475 |
bya-kangelicol |
|
C17H16O6 |
316.3 g/mol |
CC1(C(O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C |